X Square Capital, LLC Amgen Inc Transaction History

X Square Capital, LLC

$233 Million
Q1 2025

A detailed history of X Square Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, X Square Capital, LLC holds 14,386 shares of AMGN stock, worth $4.03 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares

14,386

Previous 13,941 3.19%

Holding current value

$4.03 Million

Previous $3.63 Million 23.34%

% of portfolio

1.93%

Previous 1.49%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$258.59 - $327.36 $115,072 - $145,675	445 Added 3.19%	14,386 $4.48 Million
Q4 2024 Feb 12, 2025	SELL	$258.78 - $328.31 $3,622 - $4,596	-14 Reduced 0.1%	13,941 $3.63 Million
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $105,498 - $115,046	341 Added 2.5%	13,955 $4.5 Million
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $25,749 - $31,292	-98 Reduced 0.71%	13,614 $4.25 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $1.02 Million - $1.23 Million	3,799 Added 38.32%	13,712 $3.82 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $415,768 - $469,035	-1,626 Reduced 14.09%	9,913 $2.86 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $53,781 - $63,595	-251 Reduced 2.13%	11,539 $2.56 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $39,061 - $47,609	-173 Reduced 1.45%	11,790 $2.85 Million
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $957,345 - $1.22 Million	4,180 Added 53.71%	11,963 $3.14 Million
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $5,162 - $5,822	23 Added 0.3%	7,783 $1.75 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $23,301 - $25,930	-101 Reduced 1.28%	7,760 $1.89 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $4,604 - $5,093	21 Added 0.27%	7,861 $1.9 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $303,888 - $347,772	1,528 Added 24.21%	7,840 $1.76 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $369,986 - $433,484	1,743 Added 38.15%	6,312 $1.34 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $243,857 - $270,542	1,044 Added 29.62%	4,569 $1.11 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $88,098 - $102,664	397 Added 12.69%	3,525 $877,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $37,433 - $44,576	173 Added 5.85%	3,128 $719,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $289,088 - $321,490	1,232 Added 71.5%	2,955 $751,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $22,352 - $27,429	113 Added 7.02%	1,723 $406,000
Q1 2020 May 19, 2020	SELL	$182.24 - $241.7 $65,424 - $86,770	-359 Reduced 18.23%	1,610 $326,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $31,030 - $39,884	164 Added 9.09%	1,969 $475,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $314,268 - $376,559	1,805 New	1,805 $349,000

Others Institutions Holding AMGN

# of Institutions

3,267

Shares Held

422M

Call Options Held

6.98M

Put Options Held

6.33M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on X Square Capital, LLC with notifications on news.

Account

X Square Capital, LLC Amgen Inc Transaction History